कृपया अन्य खोज का प्रयास करें
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health. The company’s medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company’s products in development include FB1002, an all-injectable long-acting HIV therapy; FB2001, a SARS-CoV-2 3CL protease inhibitor under clinical development for hospitalized patients as well as for post-exposure prophylaxis of Covid-19; FB3001, a new transdermal topical patch for musculoskeletal joint pain treatment under clinical development; and FB600, an investigational therapeutic peptide vaccine targeting PCSK9 to treat hypercholesterolemia. The company was founded in 2013 and is headquartered in Nanjing, China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Rongjian Lu | 61 | 2016 | CTO & Director |
Dong Xie | 57 | 2002 | Founder, Chairman & Chief Scientific Officer |
Chi Kit Ng | 49 | 2019 | Independent Director |
Xian Wang | 56 | 2019 | Independent Director |
Kai Chen | 64 | 2019 | Independent Director |
Zhi Zhong Jiang | 41 | 2016 | Chairman of the Supervisory Board & Deputy Director of Material Control |
Honghai Wen | 58 | 2018 | Director |
Changjin Wang | 65 | 2016 | CEO & Director |
Yuting Zhu | 35 | 2019 | Supervisor & Deputy Administrative Director |
Yuantao Cao | 43 | 2018 | Supervisor |
Guangji Wang | 71 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है